FDA Provides COVID-19 Resources
The agency has added a COVID-19 innovation resource page and an education resources page to its website.
To provide the public with information regarding COVID-19, FDA has created two web pages on its website: "Innovation to Respond to COVID-19" and "Educational Resources". Innovation to Respond to COVID-19 lists FDA’s innovative approaches to respond to COVID-19. It provides updates to connect manufacturers and healthcare entities, analysis of real-world data, the Coronavirus Treatment Acceleration Program, and guidance documents that promote innovation. Educational Resources provides links to COVID-19-related resources that help explain FDA’s work, including videos, a social media kit, consumer articles, and more.
Source: FDA
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
